Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02278250
Title An Open-Label Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of M4344 (Formerly VX-803) as a Single Agent and in Combination With Cytotoxic Chemotherapy in Participants With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors EMD Serono Research & Development Institute, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | GBR | ESP

Facility Status City State Zip Country Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-5901 United States Details
Washington University in St. Louis Saint Louis Missouri 63110 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 8903 United States Details
Memorial Sloan-Kettering Cancer Center (MSKCC) New York New York 10065 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
Froedtert & The Medical College of Wisconsin Wauwatosa Wisconsin 53226 United States Details
Erasmus Medisch Centrum Rotterdam 3075 EA Netherlands Details
Hospital Clinic de Barcelona Barcelona Spain Details
Hospital Universitari Vall d'Hebron Barcelona Spain Details
"Fundacion Jimenez Diaz START Madrid. Oncology Phase I" Madrid Spain Details
START Madrid. Fundacion Jimenez Diaz- Oncologia-Fase I Madrid Spain Details
"Hospital Clinico Universitario de Valencia Servicio de Hematologia y Oncologia Medica" Valencia Spain Details
Sarah Cannon Research Institute UK London Greater London W1G 6AD United Kingdom Details
Royal Marsden Hospital Sutton Surrey United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field